Analgesic and NSAID-induced kidney disease:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Oxford u.a.
Oxford Univ. Press
1993
|
| Schriftenreihe: | Oxford monographs on clinical nephrology
2 |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | XVII, 287 S. |
| ISBN: | 019261956X |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV008038329 | ||
| 003 | DE-604 | ||
| 005 | 20130715 | ||
| 007 | t | ||
| 008 | 930716s1993 |||| 00||| engod | ||
| 020 | |a 019261956X |9 0-19-261956-X | ||
| 035 | |a (OCoLC)26094689 | ||
| 035 | |a (DE-599)BVBBV008038329 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-355 | ||
| 050 | 0 | |a RC918.N45 | |
| 082 | 0 | |a 616.6/1 |2 20 | |
| 084 | |a XI 2065 |0 (DE-625)152980:12972 |2 rvk | ||
| 245 | 1 | 0 | |a Analgesic and NSAID-induced kidney disease |c ed. by J. H. Stewart |
| 264 | 1 | |a Oxford u.a. |b Oxford Univ. Press |c 1993 | |
| 300 | |a XVII, 287 S. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Oxford monographs on clinical nephrology |v 2 | |
| 490 | 0 | |a Oxford medical publications | |
| 650 | 4 | |a Analgesics |x Toxicology | |
| 650 | 4 | |a Analgesics |x adverse effects | |
| 650 | 4 | |a Anti-Inflammatory Agents, Non-Steroidal |x adverse effects | |
| 650 | 4 | |a Kidney Diseases |x chemically induced | |
| 650 | 4 | |a Kidneys |x Effect of drugs on | |
| 650 | 4 | |a Nephrotoxicology | |
| 650 | 4 | |a Nonsteroidal anti-inflammatory agents |x Toxicology | |
| 650 | 0 | 7 | |a Nichtsteroidales Antiphlogistikum |0 (DE-588)4209813-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelnebenwirkung |0 (DE-588)4003134-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Nierenkrankheit |0 (DE-588)4075399-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Nephrotoxizität |0 (DE-588)4041618-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Analgetikum |0 (DE-588)4001848-9 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Analgetikum |0 (DE-588)4001848-9 |D s |
| 689 | 0 | 1 | |a Nephrotoxizität |0 (DE-588)4041618-5 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Nichtsteroidales Antiphlogistikum |0 (DE-588)4209813-0 |D s |
| 689 | 1 | 1 | |a Nephrotoxizität |0 (DE-588)4041618-5 |D s |
| 689 | 1 | |5 DE-604 | |
| 689 | 2 | 0 | |a Analgetikum |0 (DE-588)4001848-9 |D s |
| 689 | 2 | 1 | |a Arzneimittelnebenwirkung |0 (DE-588)4003134-2 |D s |
| 689 | 2 | 2 | |a Nierenkrankheit |0 (DE-588)4075399-2 |D s |
| 689 | 2 | |5 DE-604 | |
| 689 | 3 | 0 | |a Nichtsteroidales Antiphlogistikum |0 (DE-588)4209813-0 |D s |
| 689 | 3 | 1 | |a Arzneimittelnebenwirkung |0 (DE-588)4003134-2 |D s |
| 689 | 3 | 2 | |a Nierenkrankheit |0 (DE-588)4075399-2 |D s |
| 689 | 3 | |5 DE-604 | |
| 700 | 1 | |a Stewart, J. H. |e Sonstige |4 oth | |
| 830 | 0 | |a Oxford monographs on clinical nephrology |v 2 |w (DE-604)BV008038322 |9 2 | |
| 856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=005288506&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-005288506 | ||
Datensatz im Suchindex
| _version_ | 1804122402565652480 |
|---|---|
| adam_text | ANALGESIC AND NSAID-INDUCED KIDNEY DISEASE EDITED BY J.H.STEWART
ASSOCIATE DEAN, WESTERN CLINICAL SCHOOL UNIVERSITY OF SYDNEY, AUSTRALIA
OXFORD NEW YORK TOKYO MELBOURNE OXFORD UNIVERSITY PRESS 1993 CONTENTS
LIST OF CONTRIBUTORS XVI 1 HISTORICAL INTRODUCTION I PHENACETIN
NEPHRITIS IN SWITZERLAND I RENAL PAPILLARY NECROSIS IN SCANDINAVIA AND
AUSTRALIA 2 THE ASSOCIATION WITH UROTHELIAL CANCER 2 THE PATHOLOGY OF
ANALGESIC NEPHROPATHY 3 THE AETIOLOGY OF ANALGESIC NEPHROPATHY 3
UNANSWERED QUESTIONS 4 2 THE BIOCHEMISTRY AND PHARMACOLOGY OF
ANTIPYRETIC-ANALGESICS 5 ASPIRIN AND SALICYLATE 5 CHEMISTRY 5
PHARMACOKINETICS 6 MODE OF ACTION 8 TOXICITY 9 PARACETAMOL
(ACETAMINOPHEN) 9 PHARMACOKINETICS 10 MECHANISM OF ACTION AND
PHARMACOLOGICAL PROPERTIES 12 TOXICITY 12 PHENACETIN 13 PHARMACOKINETICS
13 ACTION 14 TOXICITY 14 PYRAZOLONS 15 PHARMACOLOGY . 15 CONCLUSIONS 16
3 EXPERIMENTAL EVIDENCE FOR NEPHROTOXICITY OF ANALGESICS 17 SUMMARY OF
EXPERIMENTAL RESULTS 17 PHENACETIN 17 PARACETAMOL 19 ASPIRIN 22 VIII
ANALGESIC AND NSAID-INDUCED KIDNEY DISEASE CAFFEINE 23 PYRAZOLON
DERIVATIVES 23 INDOMETHACIN 24 FENEMATES 24 PROPIONIC ACID DERIVATIVES
24 MIXED ANALGESICS 24 CAUSATION OF RENAL PAPILLARY NECROSIS 26
COUNTERCURRENT CONCENTRATION 26 MEDULLARY ISCHAEMIA 27 DISTURBED
ARACHIDONIC ACID AND PROSTAGLANDIN METABOLISM 27 METABOLIC ACTIVATION
AND CHANGES IN INTERMEDIARY METABOLISM 27 PATHOGENESIS OF EXPERIMENTAL
RENAL PAPILLARY NECROSIS AND CHRONIC INTERSTITIAL NEPHRITIS 29 THE
AETIOLOGICAL AGENT 30 4 THE IMPLICATION OF ANALGESICS IN HUMAN KIDNEY
DISEASE 32 QUANTIFICATION OF THE PROBLEM 33 PREVALENCE OF ANALGESIC
NEPHROPATHY 33 GEOGRAPHICAL VARIATION IN THE PREVALENCE OF ANALGESIC
NEPHROPATHY 36 IS THE PREVALENCE OF ANALGESIC NEPHROPATHY
UNDERESTIMATED? 36 THE RELATION BETWEEN ANALGESIC ABUSE AND KIDNEY
DISEASE 38 CLINICAL OBSERVATIONS 38 EPIDEMIOLOGICAL STUDIES 38
NEPHROTOXICITY OF DIFFERENT KINDS OF ANALGESICS 42 PHENACETIN
MISCONCEPTION 42 THE NEPHROTOXICITY OF SINGLE ANALGESICS 42 THE
NEPHROTOXICITY OF ANALGESIC MIXTURES 43 EFFECTS OF LEGISLATIVE MEASURES
45 CONCLUSION 46 5 THE ABUSE OF NON-NARCOTIC ANALGESICS 48
SYMPTOMATOLOGY AND AETIOLOGY OF THE ABUSE OF NON-NARCOTIC ANALGESICS 48
REASONS GIVEN FOR ANALGESIC CONSUMPTION 48 PSYCHOSOMATIC BASIS FOR
ANALGESIC ABUSE 50 THE ONSET OF DRUG HABITUATION 51 DRUG WITHDRAWAL 51
CONTENTS IX PSYCHOLOGICAL ASPECTS OF DRUG USE PATTERNS 52 DO CONSUMERS
DIFFER FROM NON-CONSUMERS WITH REGARD TO PERSONALITY? 53 DO GROUPS OF
CONSUMERS WITH VARYING PATTERNS OF USE DIFFER? 55 TREATMENT AND
PREVENTION 57 6 THE ANALGESIC SYNDROME 58 CAFFEINE 60 WITHDRAWAL
HEADACHE 60 DIRECT CAFFEINE TOXICITY 60 CODEINE 61 ASPIRIN AND
SALICYLATES 61 GASTRIC ULCER 61 BLEEDING TENDENCY 63 PERINATAL MORBIDITY
AND MORTALITY 63 PHENACETIN AND PARACETAMOL 64 CYANOSIS, HAEMOLYSIS, AND
SPLENOMEGALY 64 PIGMENTATION 64 PYRAZOLON DERIVATIVES 64 DISORDERS OF
MIXED OR UNCERTAIN AETIOLOGY 64 CENTRAL NERVOUS SYSTEM TOXICITY 64
ACCELERATED ATHEROGENESIS 65 PREMATURE AGEING 65 A TYPICAL ANALGESIC
HABITUE 65 7 THE PATHOLOGY OF ANALGESIC NEPHROPATHY 67 THE LESIONS OF
ANALGESIC-INDUCED RENAL DISEASE 67 CAPILLARY SCLEROSIS 67 DEVELOPMENT OF
PAPILLARY NECROSIS 68 THE RELATIONSHIP OF CORTICAL CHANGE TO PAPILLARY
NECROSIS 74 FULLY DEVELOPED ANALGESIC NEPHROPATHY 77 PATHOGENESIS OF
ANALGESIC-INDUCED LESIONS 79 SPECIFICITY OF THE ANALGESIC-INDUCED LESION
80 COMPLICATIONS OF ANALGESIC NEPHROPATHY 81 HYPERTENSION 81
PYELONEPHRITIS 81 OBSTRUCTION 82 CYSTS 82 UROTHELIOMA 82 ANALGESIC AND
NSAID-INDUCED KIDNEY DISEASE CORRELATION BETWEEN CLINICAL PRESENTATION
AND MORPHOLOGY CESSATION OF ANALGESIC ABUSE CONCLUDING REMARKS 8 THE
DIAGNOSIS OF ANALGESIC NEPHROPATHY BY ORGAN IMAGING MORPHOLOGICAL
FEATURES OF ANALGESIC NEPHROPATHY EARLY SIGNS PARTIAL PAPILLARY NECROSIS
TOTAL PAPILLARY NECROSIS NECROSIS IN SITU THE OUTCOME OF PAPILLARY
SLOUGHING PARENCHYMAL CHANGES IN ANALGESIC NEPHROPATHY TRANSITIONAL CELL
CARCINOMA IMAGING TECHNIQUES PYELOGRAPHY ULTRASONOGRAPHY COMPUTED
TOMOGRAPHY AND PLAIN FILM RADIOLOGY DIFFERENTIAL DIAGNOSIS NORMAL KIDNEY
CALYCEAL CYSTS REFLUX NEPHROPATHY (CHRONIC PYELONEPHRITIS) MEDULLARY
SPONGE KIDNEY HYDRONEPHROTIC ATROPHY TUBERCULOSIS METABOLIC
NEPHROCALCINOSIS 9 FUNCTIONAL DEFECTS IN ANALGESIC NEPHROPATHY URINARY
ABNORMALITIES MICROSCOPY PROTEINURIA ACUTE URINARY RESPONSE TO ANALGESIC
INGESTION RENAL DYSFUNCTION GLOMERULAR FILTRATION RATE TUBULAR
DYSFUNCTION CONSEQUENCES OF RENAL IMPAIRMENT HYPERURICAEMIA HYPERTENSION
RENAL OSTEODYSTROPHY EFFECT OF CESSATION OF ANALGESIC ABUSE 82 83 85 86
86 86 86 88 88 89 89 89 94 94 95 96 96 98 98 98 99 IOI IOI IOI 102 102
102 102 103 103 103 103 106 106 106 107 107 CONTENTS XI 10 CLINICAL
PRESENTATIONS OF ANALGESIC NEPHROPATHY 108 APPROACH TO THE EVALUATION OF
PATIENTS 108 DRUG HISTORY 108 CLINICAL EXAMINATION NO SPECIFIC DIAGNOSIS
OF ANALGESIC NEPHROPATHY IN MAJOR CLINICAL PRESENTATIONS IN RENAL
INSUFFICIENCY 111 ABNORMAL URINARY FINDINGS 113 HYPERTENSION 113
PAPILLARY NECROSIS AND CALCULUS FORMATION 114 URINARY OBSTRUCTION 114
THE VALUE OF RENAL BIOPSY 115 RENAL TRANSPLANT FAILURE 115 ANALGESIC
INTAKE IN PATIENTS WITH INTRINSIC RENAL DISEASE 116 SUMMARY 117 11
TREATMENT OF RENAL FAILURE DUE TO ANALGESICS 119 PREVENTION OF FURTHER
ABUSE 119 PROGRESSION OF ANALGESIC NEPHROPATHY 121 DISCONTINUATION OF
ANALGESIC INTAKE 121 GLOMERULOSCLEROSIS 121 RENAL ARTERY STENOSIO 121
ACUTE RENAL FAILURE 122 MANAGEMENT OF COMPLICATIONS 123 URINARY TRACT
INFECTIONS 123 SALT-LOSING NEPHROPATHY 123 RENAL OSTEODYSTROPHY 123
ARTERIAL HYPERTENSION 125 ACCELERATED ATHEROGENESIS 125 ANAEMIA 126
CARCINOMA 126 HAEMODIALYSIS 127 ACCEPTANCE FOR MAINTENANCE DIALYSIS 127
RENAL TRANSPLANTATION 129 SUMMARY 131 12 BIOCHEMISTRY AND PHARMACOLOGY
OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND RENAL PROSTAGLANDINS 133
BIOCHEMISTRY AND DISTRIBUTION OF RENAL EICOSANOIDS 135 XII ANALGESIC AND
NSAID-INDUCED KIDNEY DISEASE RELEASE OF ARACHIDONIC ACID 135 OXIDATION
OF ARACHIDONIC ACID 135 DEGRADATION AND ELIMINATION OF EICOSANOIDS 136
RENAL DISTRIBUTION OF EICOSANOIDS 136 SYNTHESIS AND PHYSIOLOGY OF
GLOMERULAR EICOSANOIDS 137 SYNTHESIS 137 VASOMOTOR ACTION OF GLOMERULAR
EICOSANOIDS 138 MODIFICATION OF INFLAMMATORY RESPONSES BY GLOMERULAR
EICOSANOIDS 139 SYNTHESIS AND PHYSIOLOGY OF TUBULAR EICOSANOIDS 139
SYNTHESIS 139 FUNCTIONS 139 EFFECTS OF LOCAL INHIBITION OF
CYCLOOXYGENASE 141 INACTIVATION OF RENAL CYCLOOXYGENASE 142 DIFFERENTIAL
INHIBITION OF HUMAN CYCLOOXYGENASE 143 LOW DOSE ASPIRIN 144 SULINDAC 144
TISSUE SPECIFIC ACTIVITIES OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS 145
CONCLUSIONS 146 13 EFFECTS OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS ON
RENAL FUNCTION 147 PROSTAGLANDINS IN THE KIDNEY 147 MODULATORY ROLE 147
PROCESSES REGULATED BY BASAL LEVELS OF PROSTAGLANDINS 148 STATES
ASSOCIATED WITH INCREASED RENAL PROSTAGLANDIN SYNTHESIS 148 THE EFFECT
OF PROSTAGLANDINS ON RENAL FUNCTION 148 RENAL HAEMODYNAMICS 148
GLOMERULAR FUNCTION 149 TUBULAR PROCESSES 150 ENDOCRINE EFFECTS 150
RENAL EFFECTS OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS 151 NORMAL
INDIVIDUALS 151 DISEASE STATES 152 SPECIAL POPULATIONS 154 CLINICAL
SYNDROMES RESULTING FROM NON-STEROIDAL ANTI-INFLAMMATORY DRUGS 154
POTASSIUM, SODIUM, AND WATER RETENTION 156 INTRINSIC KIDNEY DISEASE 156
CONTENTS XIII RENAL SPARING NON-STEROIDAL ANTI-INFLAMMATORY DRUGS 156
SULINDAC 157 SALICYLATES 157 BENEFICIAL RENAL EFFECTS OF NON-STEROIDAL
ANTI-INFLAMMATORY DRUGS 158 LONG TERM RENAL EFFECTS OF NON-STEROIDAL
ANTI-INFLAMMATORY DRUGS 158 SUMMARY 159 ACKNOWLEDGEMENTS 159 14 DISEASES
OF THE KIDNEY CAUSED BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS 160
INCIDENCE 160 ACUTE INTERSTITIAL NEPHRITIS 161 DRUGS INVOLVED 161
CLINICAL FEATURES 164 PATHOLOGY 166 DIAGNOSIS 166 PATHOGENESIS 167
TREATMENT 167 ACUTE TUBULAR NECROSIS 168 MINIMAL CHANGE NEPHROTIC
SYNDROME 169 OTHER GLOMERULOPATHIES 170 MEMBRANOUS NEPHROPATHY 170
PROLIFERATIVE GLOMERULONEPHRITIS 170 PAPILLARY NECROSIS AND CHRONIC
RENAL FAILURE 171 OTHER LESIONS 171 TUBULAR OBSTRUCTION 172 CONCLUSIONS
172 15 PARACETAMOL-INDUCED RENAL TUBULAR CELL NECROSIS 174 EXPERIMENTAL
EVIDENCE 174 HISTOLOGICAL FINDINGS IN EXPERIMENTAL ANIMALS 175 CLINICAL
OBSERVATIONS 175 NEPHROTOXICITY WITH NO OR LITTLE LIVER DAMAGE 176
CLINICAL PRESENTATION 176 HISTOLOGICAL FINDINGS IN PATIENTS 177 SUMMARY
179 16 EXPERIMENTAL EVIDENCE AND THE BIOCHEMICAL BASIS FOR THE ROLE OF
ANALGESICS IN CANCER 180 UROTHELIAL TUMOURS*INDUCTION AND INITIATION 180
XIV ANALGESIC AND NSAID-INDUCED KIDNEY DISEASE THE AETIOLOGICAL ROLE OF
ANALGESIC ABUSE 181 PHENACETIN*AN AETIOLOGICAL RED HERRING 181
ANALGESICS AS CARCINOGENS 183 EXPERIMENTAL MODELS OF RENAL PAPILLARY
NECROSIS 184 PAPILLOTOXIN-INDUCED HISTOCHEMICAL CHANGES IN RENAL
PAPILLAE 186 THE PROBABLE MECHANISM OF RENAL PAPILLARY NECROSIS 188
UROTHELIAL HYPERPLASIA FOLLOWING RENAL PAPILLARY NECROSIS 188
EXPERIMENTAL MODELS OF UPPER UROTHELIAL CARCINOMA 190 SPONTANEOUS
UROTHELIAL CARCINOMA 191 ONE-STAGE MODELS OF UPPER UROTHELIAL
CARCINOGENESIS 191 TWO-STAGE MODELS OF UPPER UROTHELIAL CARCINOGENESIS
192 THE RELATIONSHIP BETWEEN RENAL PAPILLARY NECROSIS AND UPPER
UROTHELIAL CANCER IN MAN 194 ACKNOWLEDGEMENTS 196 17 ANALGESICS AS HUMAN
CARCINOGENS*CLINICAL AND EPIDEMIOLOGICAL EVIDENCE 197 CASE SERIES 197
FORMAL EPIDEMIOLOGICAL EVIDENCE 200 CASE*CONTROL STUDIES 200 COHORT
STUDIES 200 SUMMARY OF EVIDENCE IMPLICATING PHENACETIN OR OTHER
ANALGESIC DRUGS 201 EVIDENCE IMPLICATING RENAL PAPILLARY NECROSIS 205
POPULATION ATTRIBUTABLE RISKS 207 INCIDENCE OF RENAL PELVIC CANCER 207
SUMMARY 210 18 CARCINOMA OF THE RENAL PELVIS 211 PATHOLOGY 211 INCIDENCE
211 CLINICAL ASPECTS 212 DIAGNOSIS 213 TREATMENT 214 PROGNOSIS 215 19
PREVENTION OF ANALGESIC-INDUCED KIDNEY DISEASE 216 THE AETIOLOGY OF
ANALGESIC-INDUCED KIDNEY DISEASE 216 CONTENTS XV THE CONCLUSION BASED ON
EPIDEMIOLOGICAL EVIDENCE 217 THE CONCLUSION BASED ON LABORATORY EVIDENCE
218 STRATEGIES FOR PREVENTION 218 PROHIBITION OF PHENACETIN (AND
PARACETAMOL) 218 RESTRICTIONS ON MARKETING COMPOUND ANALGESIC
PREPARATIONS 219 EDUCATION AND LOBBYING 219 FORCES PROMOTING CONTINUANCE
OF ANALGESIC CONSUMPTION 220 THE REALITY 221 PREVENTION OF SECONDARY
RENAL DAMAGE 221 REFERENCES 223 INDEX 285
|
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV008038329 |
| callnumber-first | R - Medicine |
| callnumber-label | RC918 |
| callnumber-raw | RC918.N45 |
| callnumber-search | RC918.N45 |
| callnumber-sort | RC 3918 N45 |
| callnumber-subject | RC - Internal Medicine |
| classification_rvk | XI 2065 |
| ctrlnum | (OCoLC)26094689 (DE-599)BVBBV008038329 |
| dewey-full | 616.6/1 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.6/1 |
| dewey-search | 616.6/1 |
| dewey-sort | 3616.6 11 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02641nam a2200649 cb4500</leader><controlfield tag="001">BV008038329</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20130715 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">930716s1993 |||| 00||| engod</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">019261956X</subfield><subfield code="9">0-19-261956-X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)26094689</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV008038329</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-355</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC918.N45</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.6/1</subfield><subfield code="2">20</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 2065</subfield><subfield code="0">(DE-625)152980:12972</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Analgesic and NSAID-induced kidney disease</subfield><subfield code="c">ed. by J. H. Stewart</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Oxford u.a.</subfield><subfield code="b">Oxford Univ. Press</subfield><subfield code="c">1993</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XVII, 287 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Oxford monographs on clinical nephrology</subfield><subfield code="v">2</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Oxford medical publications</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Analgesics</subfield><subfield code="x">Toxicology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Analgesics</subfield><subfield code="x">adverse effects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anti-Inflammatory Agents, Non-Steroidal</subfield><subfield code="x">adverse effects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Kidney Diseases</subfield><subfield code="x">chemically induced</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Kidneys</subfield><subfield code="x">Effect of drugs on</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nephrotoxicology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nonsteroidal anti-inflammatory agents</subfield><subfield code="x">Toxicology</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Nichtsteroidales Antiphlogistikum</subfield><subfield code="0">(DE-588)4209813-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelnebenwirkung</subfield><subfield code="0">(DE-588)4003134-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Nierenkrankheit</subfield><subfield code="0">(DE-588)4075399-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Nephrotoxizität</subfield><subfield code="0">(DE-588)4041618-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Analgetikum</subfield><subfield code="0">(DE-588)4001848-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Analgetikum</subfield><subfield code="0">(DE-588)4001848-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Nephrotoxizität</subfield><subfield code="0">(DE-588)4041618-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Nichtsteroidales Antiphlogistikum</subfield><subfield code="0">(DE-588)4209813-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Nephrotoxizität</subfield><subfield code="0">(DE-588)4041618-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Analgetikum</subfield><subfield code="0">(DE-588)4001848-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Arzneimittelnebenwirkung</subfield><subfield code="0">(DE-588)4003134-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="2"><subfield code="a">Nierenkrankheit</subfield><subfield code="0">(DE-588)4075399-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="3" ind2="0"><subfield code="a">Nichtsteroidales Antiphlogistikum</subfield><subfield code="0">(DE-588)4209813-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2="1"><subfield code="a">Arzneimittelnebenwirkung</subfield><subfield code="0">(DE-588)4003134-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2="2"><subfield code="a">Nierenkrankheit</subfield><subfield code="0">(DE-588)4075399-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Stewart, J. H.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Oxford monographs on clinical nephrology</subfield><subfield code="v">2</subfield><subfield code="w">(DE-604)BV008038322</subfield><subfield code="9">2</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=005288506&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-005288506</subfield></datafield></record></collection> |
| id | DE-604.BV008038329 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-09T17:13:18Z |
| institution | BVB |
| isbn | 019261956X |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-005288506 |
| oclc_num | 26094689 |
| open_access_boolean | |
| owner | DE-12 DE-355 DE-BY-UBR |
| owner_facet | DE-12 DE-355 DE-BY-UBR |
| physical | XVII, 287 S. |
| publishDate | 1993 |
| publishDateSearch | 1993 |
| publishDateSort | 1993 |
| publisher | Oxford Univ. Press |
| record_format | marc |
| series | Oxford monographs on clinical nephrology |
| series2 | Oxford monographs on clinical nephrology Oxford medical publications |
| spelling | Analgesic and NSAID-induced kidney disease ed. by J. H. Stewart Oxford u.a. Oxford Univ. Press 1993 XVII, 287 S. txt rdacontent n rdamedia nc rdacarrier Oxford monographs on clinical nephrology 2 Oxford medical publications Analgesics Toxicology Analgesics adverse effects Anti-Inflammatory Agents, Non-Steroidal adverse effects Kidney Diseases chemically induced Kidneys Effect of drugs on Nephrotoxicology Nonsteroidal anti-inflammatory agents Toxicology Nichtsteroidales Antiphlogistikum (DE-588)4209813-0 gnd rswk-swf Arzneimittelnebenwirkung (DE-588)4003134-2 gnd rswk-swf Nierenkrankheit (DE-588)4075399-2 gnd rswk-swf Nephrotoxizität (DE-588)4041618-5 gnd rswk-swf Analgetikum (DE-588)4001848-9 gnd rswk-swf Analgetikum (DE-588)4001848-9 s Nephrotoxizität (DE-588)4041618-5 s DE-604 Nichtsteroidales Antiphlogistikum (DE-588)4209813-0 s Arzneimittelnebenwirkung (DE-588)4003134-2 s Nierenkrankheit (DE-588)4075399-2 s Stewart, J. H. Sonstige oth Oxford monographs on clinical nephrology 2 (DE-604)BV008038322 2 GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=005288506&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Analgesic and NSAID-induced kidney disease Oxford monographs on clinical nephrology Analgesics Toxicology Analgesics adverse effects Anti-Inflammatory Agents, Non-Steroidal adverse effects Kidney Diseases chemically induced Kidneys Effect of drugs on Nephrotoxicology Nonsteroidal anti-inflammatory agents Toxicology Nichtsteroidales Antiphlogistikum (DE-588)4209813-0 gnd Arzneimittelnebenwirkung (DE-588)4003134-2 gnd Nierenkrankheit (DE-588)4075399-2 gnd Nephrotoxizität (DE-588)4041618-5 gnd Analgetikum (DE-588)4001848-9 gnd |
| subject_GND | (DE-588)4209813-0 (DE-588)4003134-2 (DE-588)4075399-2 (DE-588)4041618-5 (DE-588)4001848-9 |
| title | Analgesic and NSAID-induced kidney disease |
| title_auth | Analgesic and NSAID-induced kidney disease |
| title_exact_search | Analgesic and NSAID-induced kidney disease |
| title_full | Analgesic and NSAID-induced kidney disease ed. by J. H. Stewart |
| title_fullStr | Analgesic and NSAID-induced kidney disease ed. by J. H. Stewart |
| title_full_unstemmed | Analgesic and NSAID-induced kidney disease ed. by J. H. Stewart |
| title_short | Analgesic and NSAID-induced kidney disease |
| title_sort | analgesic and nsaid induced kidney disease |
| topic | Analgesics Toxicology Analgesics adverse effects Anti-Inflammatory Agents, Non-Steroidal adverse effects Kidney Diseases chemically induced Kidneys Effect of drugs on Nephrotoxicology Nonsteroidal anti-inflammatory agents Toxicology Nichtsteroidales Antiphlogistikum (DE-588)4209813-0 gnd Arzneimittelnebenwirkung (DE-588)4003134-2 gnd Nierenkrankheit (DE-588)4075399-2 gnd Nephrotoxizität (DE-588)4041618-5 gnd Analgetikum (DE-588)4001848-9 gnd |
| topic_facet | Analgesics Toxicology Analgesics adverse effects Anti-Inflammatory Agents, Non-Steroidal adverse effects Kidney Diseases chemically induced Kidneys Effect of drugs on Nephrotoxicology Nonsteroidal anti-inflammatory agents Toxicology Nichtsteroidales Antiphlogistikum Arzneimittelnebenwirkung Nierenkrankheit Nephrotoxizität Analgetikum |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=005288506&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV008038322 |
| work_keys_str_mv | AT stewartjh analgesicandnsaidinducedkidneydisease |